X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (57) 57
Publication (6) 6
Conference Proceeding (5) 5
Patent (2) 2
Book Chapter (1) 1
Dissertation (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27) 27
male (19) 19
adult (18) 18
female (16) 16
hiv infections - drug therapy (16) 16
index medicus (15) 15
middle aged (15) 15
drug therapy (12) 12
research (12) 12
abacavir (11) 11
infectious diseases (11) 11
lamivudine (11) 11
hiv infections - virology (9) 9
tenofovir (9) 9
therapy (9) 9
aged (8) 8
drug therapy, combination (8) 8
hiv-1 - drug effects (8) 8
hiv-1 - genetics (8) 8
adolescent (7) 7
anti-hiv agents - therapeutic use (7) 7
antiviral agents (7) 7
efavirenz (7) 7
hiv (7) 7
immunology (7) 7
lamivudine - therapeutic use (7) 7
treatment outcome (7) 7
aids/hiv (6) 6
emtricitabine (6) 6
health aspects (6) 6
hiv infection (6) 6
ritonavir (6) 6
viral load (6) 6
virology (6) 6
young adult (6) 6
adults (5) 5
anti-hiv agents - administration & dosage (5) 5
anti-hiv agents - adverse effects (5) 5
cd4 lymphocyte count (5) 5
dideoxynucleosides - therapeutic use (5) 5
dolutegravir (5) 5
human immunodeficiency virus--hiv (5) 5
mupirocin (5) 5
pharmacology & pharmacy (5) 5
ritonavir - therapeutic use (5) 5
adenine - analogs & derivatives (4) 4
anti-hiv agents - pharmacology (4) 4
antiretroviral drugs (4) 4
double-blind method (4) 4
drug administration schedule (4) 4
drug combinations (4) 4
heterocyclic compounds, 3-ring - therapeutic use (4) 4
infection (4) 4
medicine, general & internal (4) 4
once-daily dolutegravir (4) 4
ritonavir - administration & dosage (4) 4
ritonavir - adverse effects (4) 4
rna, viral - blood (4) 4
safety (4) 4
sulfonamides - administration & dosage (4) 4
time factors (4) 4
usage (4) 4
abridged index medicus (3) 3
aged, 80 and over (3) 3
anti-retroviral agents - adverse effects (3) 3
antiretroviral therapy, highly active (3) 3
antiretroviral therapy, highly active - methods (3) 3
atazanavir (3) 3
carbamates - administration & dosage (3) 3
clinical science (3) 3
clinical trials (3) 3
clinical trials as topic (3) 3
drug resistance, viral (3) 3
drug-resistance (3) 3
gastroesophageal reflux disease (3) 3
heartburn (3) 3
hiv infections - immunology (3) 3
hiv-1 - isolation & purification (3) 3
initial treatment (3) 3
lamivudine - administration & dosage (3) 3
lamivudine - adverse effects (3) 3
mutation (3) 3
organophosphates - administration & dosage (3) 3
physics (3) 3
raltegravir (3) 3
ranitidine (3) 3
sulfonamides - adverse effects (3) 3
sulfonamides - therapeutic use (3) 3
virus diseases (3) 3
abacavir/lamivudine (2) 2
active antiretroviral therapy (2) 2
adenine - administration & dosage (2) 2
adenine - pharmacology (2) 2
adenine - therapeutic use (2) 2
aids (2) 2
amprenavir (2) 2
analysis (2) 2
anti-hiv agents (2) 2
anti-retroviral agents - administration & dosage (2) 2
anti-retroviral agents - therapeutic use (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2013, Volume 369, Issue 19, pp. 1807 - 1818
Journal Article
Journal Article
by Cahn, Pedro and Madero, Juan Sierra and Arribas, José Ramón and Antinori, Andrea and Ortiz, Roberto and Clarke, Amanda E and Hung, Chien-Ching and Rockstroh, Jürgen K and Girard, Pierre-Marie and Sievers, Jörg and Man, Choy and Currie, Alexander and Underwood, Mark and Tenorio, Allan R and Pappa, Keith and Wynne, Brian and Fettiplace, Anna and Gartland, Martin and Aboud, Michael and Smith, Kimberly and Cassetti, Lidia and David, Daniel and Figueras, Laura and Losso, Marcelo and Lopardo, Gustavo and Lupo, Sergio and Porteiro, Norma and Sánchez, Marisa and Bloch, Mark and Cooper, David and Finlayson, Robert and Kelleher, Anthony and Koh, Kenneth and Lewis, David and McMahon, James and Moore, Richard and Roth, Norman and Shields, Matthew and De Wit, Stephane and Florence, Eric and Goffard, Jean-Christophe and Demeester, Remy and Lacor, Patrick and Vandercam, Bernard and Vandekerckhove, Linos and Angel, Jonathan and Baril, Jean-Guy and Conway, Brian and De Pokomandy, Alexandra and Szabo, Jason and Walmsley, Sharon and Bouchaud, Olivier and Chidiac, Christian and Delobel, Pierre and Goujard, Cecile and Katlama, Christine and Molina, Jean-Michel and Pialoux, Gilles and Philibert, Patrick and Bogner, Johannes and Esser, Stefan and Krznaric, Ivanka and Lehmann, Clara and Spinner, Christoph and Stellbrink, Hans-Jurgen and Stephan, Christoph and Stoehr, Albrecht and Barchi, Enrico and Caramello, Pietro and Castelli, Francesco and Cattelan, Anna Maria and D'Arminio Monforte, Antonella and Di Biagio, Antonio and Di Perri, Giovanni and Gori, Andrea and Maggiolo, Franco and Menzaghi, Barbara and Migliorino, Guglielmo and Mussini, Cristina and Penco, Giovanni and Puoti, Massimo and Rizzardini, Giuliano and Gulminetti, Roberto and Lazzarin, Adriano and Quirino, Tiziano and Sighinolfi, Laura and Viale, Pierluigi and Amaya Tapia, Gerardo and Andrade Villanueva, Jaime and Granados Reyes, Enrique R and Perez Rios, Alma and Santoscoy Gomez, Mario and Den Hollander, Jan and Rijnders, Bart and Hidalgo, José A and Hercilla Vasquez, Luis and Illescas, Luis and Olczak, Anita and Mansinho, Kamal and Correia Pacheco, Patricia Paula and ... and GEMINI Study Team
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10167, pp. 143 - 155
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 2011, Volume 154, Issue 7, pp. 445 - 456
Background: Limited data compare once-daily options for initial therapy for HIV-1. Objective: To compare time to virologic failure; first grade-3 or -4 sign,... 
Atazanavir | Ritonavir | Research | Drug therapy | Health aspects | Efavirenz | HIV infection
Journal Article
AIDS Research and Therapy, ISSN 1742-6405, 03/2008, Volume 5, Issue 1, pp. 5 - 5
Once-daily (QD) ritonavir 100 mg-boosted fosamprenavir 1400 mg (FPV/r100) or atazanavir 300 mg (ATV/r100), plus tenofovir/emtricitabine (TDF/FTC) 300 mg/200... 
Antiviral agents | Dosage and administration | Research | Drug therapy | Ritonavir | HIV infection
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 2015, Volume 70, Issue 5, pp. 515 - 519
The SINGLE study was a randomized, double-blind, noninferiority study that evaluated the safety and efficacy of 50 mg dolutegravir + abacavir/lamivudine versus... 
Lamivudine | HIV | Abacavir | Dolutegravir | INFECTIOUS DISEASES | ONCE-DAILY DOLUTEGRAVIR | RALTEGRAVIR | ADULTS | abacavir | dolutegravir | IMMUNOLOGY | lamivudine
Journal Article
ANNALS OF INTERNAL MEDICINE, ISSN 0003-4819, 04/2011, Volume 154, Issue 7, p. 445
Journal Article
AIDS, ISSN 0269-9370, 01/2015, Volume 29, Issue 2, pp. 167 - 174
Journal Article
HIV/AIDS - Research and Palliative Care, ISSN 1179-1373, 01/2011, Volume 3, pp. 1 - 8
Renal impairment in human immunodeficiency virus (HIV)-infected patients could potentially be caused by many factors. HIV-related renal impairment risks have... 
Tenofovir | Nephropathy | African american | Comorbidities | Hispanic | Antiretroviral therapy | Studies | Hypertension | African Americans | Hepatitis | Human immunodeficiency virus--HIV | Hispanics | nephropathy | comorbidities | tenofovir | antiretroviral therapy | African American
Journal Article
Journal Article
Open Forum Infectious Diseases, ISSN 2328-8957, 10/2019, Volume 6, Issue Supplement_2, pp. S67 - S68
Abstract Background At Weeks 48 and 96 in the GEMINI-1 and GEMINI-2 studies (Clinicaltrials.gov: NCT02831673 and NCT02831764), the 2DR of DTG+3TC was... 
Journal Article